ALPINE IMMUNE SCIENCES INC shareholders Q3 2023

ALPINE IMMUNE SCIENCES INC's ticker is ALPN and the CUSIP is 02083G100. A total of 89 filers reported holding ALPINE IMMUNE SCIENCES INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.8%.

ALPINE IMMUNE SCIENCES INC shareholders Q3 2023
NameSharesValueWeighting ↓
STATE OF WISCONSIN INVESTMENT BOARD 22,197$254,1560.00%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 234,256$2,682,2310.00%
AMERICAN INTERNATIONAL GROUP, INC. 15,842$181,3910.00%
METROPOLITAN LIFE INSURANCE CO/NY 1,743$19,9570.00%
Invesco Ltd. 217,136$2,486,2070.00%
Ameritas Investment Partners, Inc. 2,621$30,0100.00%
BlackRock Inc. 2,351,917$26,929,4510.00%
SG Americas Securities, LLC 9,927$1140.00%
NORTHERN TRUST CORP 270,424$3,096,3540.00%
RHUMBLINE ADVISERS 41,403$474,0530.00%
D. E. Shaw & Co., Inc. 48,631$556,8250.00%
CITIGROUP INC 670$7,6720.00%
GOLDMAN SACHS GROUP INC 66,445$760,7960.00%
MORGAN STANLEY 53,473$612,2650.00%
WELLINGTON MANAGEMENT GROUP LLP 39,731$454,9200.00%
AMALGAMATED BANK 3,656$420.00%
ROYAL BANK OF CANADA 6,323$72,0000.00%
Bank of New York Mellon Corp 92,723$1,061,6780.00%
Citadel Advisors 1,700$19,4650.00%
Citadel Advisors 28,174$322,5920.00%
External links

This page lists ALPINE IMMUNE SCIENCES INC's shareholders in Q3 2023. To view ALPINE IMMUNE SCIENCES INC's shareholder history, click here.